BSX BOSTON SCIENTIFIC CORP

2026Q1 · CUSIP 101137107 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price

Holders

1,661

Δ holders QoQ

-121

Breadth percentile

Top 99%

Whale holders

359

Δ whales

-4

Inst. holding value

$82.1B

New positions

193

Closed positions

314

Price momentum (1Q)

-26.7%

Put / Call

37/52

Breadth history (34 quarters)

Past Lit Events & Aftermath 22 lit events

Period	Percentile	Next-1Q return	Next-2Q return
2025Q4	Top 6%	-26.7%	—
2025Q3	Top 19%	-25.6%	-44.3%
2025Q2	Top 5%	-0.3%	-26.0%
2025Q1	Top 0%	-2.7%	-4.6%
2024Q4	Top 3%	+1.2%	-1.5%
2024Q3	Top 2%	+15.5%	+15.5%
2024Q2	Top 1%	+11.9%	+35.0%
2024Q1	Top 2%	+5.4%	+16.5%
2023Q4	Top 4%	+13.4%	+19.5%
2023Q2	Top 1%	+5.0%	+28.4%
2023Q1	Top 1%	-4.6%	+0.8%
2022Q4	Top 5%	+15.0%	+8.0%
2022Q1	Top 12%	+2.7%	+2.7%
2021Q3	Top 11%	+6.7%	-2.9%
2021Q2	Top 6%	-5.8%	-4.3%
2020Q2	Top 9%	-3.5%	-4.7%
2019Q4	Top 4%	-13.6%	-6.7%
2019Q3	Top 7%	+0.5%	-12.1%
2019Q1	Top 2%	+12.9%	+11.4%
2018Q4	Top 7%	-6.4%	+7.2%
2018Q3	Top 7%	+7.8%	+1.4%
2018Q2	Top 4%	+5.6%	+16.2%

Show all 22 events

Options Sentiment

Put holders

QoQ: +3

Call holders

QoQ: +17

See methodology →

Fundamentals

PE (TTM)

18.4

EPS (TTM)

$2.39

EPS YoY

+74.5%

Revenue (TTM)

$20.6B

Revenue YoY

+17.4%

Net margin

17.3%

ROE

13.8%

Debt ratio

41.7%

FCF (TTM)

$3.5B

Dividend (TTM)

No dividend

Quarterly Revenue & EPS (4Y)

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.